1. Share Prices

  2. Dechra Pharmaceuticals PLC (DPH)

3,487.66p+59.66 (+1.74%)27 Jun 2022, 12:23
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Dechra Pharmaceuticals PLC Fundamentals

Company NameDechra Pharmaceuticals PLCLast Updated2022-06-27
IndustryDrug Manufacturers - GeneralSectorHealthcare
Shares in Issue108.389 mMarket Cap£3.77 bn
PE Ratio51.28Dividend per Share£0.35
Dividend Yield1.21Dividend Cover1.45
EPS£0.51EPS Growth (%)0.33
PEG0DPS Growth (%)0.0840
Debt Ratio0.2690Debt Equity Ratio0.4908
Asset Equity Ratio1.8427Cash Equity Ratio0.1936
Quick Ratio1.6200Current Ratio2.91
Price To Book Value5.8140ROCE0

Dechra Pharmaceuticals PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total
Interim2022-03-032022-04-07GBP0.1200
Prelim2021-10-282021-11-19GBP0.2939
Interim2021-03-042021-04-07GBP0.1111
Prelim2020-11-052020-11-27GBP0.2400
Interim2020-03-052020-04-08GBP0.1029
Prelim2019-10-242019-11-15GBP0.2210

Dechra Pharmaceuticals PLC Company Financials

Assets202120202019
Tangible Assets£87.00 m£76.40 m£58.40 m
Intangible Assets£715.80 m£692.20 m£680.60 m
Investments£17.10 m£17.40 m£10.10 m
Total Fixed Assets£821.90 m£788.70 m£750.00 m
Stocks£149.50 m£120.80 m£103.50 m
Debtors£106.70 m£93.90 m£99.80 m
Cash & Equivalents£118.40 m£227.40 m£80.30 m
Other Assets£2.00 m£2.70 m£900,000.00
Total Assets£1.21 bn£1.24 bn£1.04 bn
Liabilities202120202019
Creditors within 1 year£155.80 m£137.30 m£118.10 m
Creditors after 1 year£425.40 m£462.80 m£414.30 m
Other Liabilities000
Total Liabilities£581.20 m£600.10 m£532.40 m
Net assets£632.90 m£637.50 m£509.10 m
Equity202120202019
Called up share capital£1.10 m£1.10 m£1.00 m
Share Premium£411.60 m£409.30 m£277.90 m
Profit / Loss£74.00 m£40.90 m£27.80 m
Other Equity£632.90 m£637.50 m£509.10 m
Preference & Minorities000
Total Capital Employed£632.90 m£637.50 m£509.10 m
Ratios202120202019
Debt Ratio£0.33£0.35£0.38
Debt-to-Equity£0.50£0.55£0.60
Assets / Equity1.84271.84271.8427
Cash / Equity0.19360.19360.1936
EPS£0.53£0.40£0.36
Cash Flow202120202019
Cash from operating activities£89.10 m£106.40 m£81.80 m
Cashflow before financing£34.00 m£225.30 m£61.70 m
Increase in Cash-£102.10 m£143.80 m-£200,000.00
Income202120202019
Turnover£608.00 m£515.10 m£481.80 m
Cost of sales£262.10 m£223.50 m£208.70 m
Gross Profit£345.90 m£291.60 m£273.10 m
Operating Profit£84.00 m£52.20 m£39.00 m
Pre-Tax profit£74.00 m£40.90 m£27.80 m

Dechra Pharmaceuticals PLC Company Background

SectorHealthcare
ActivitiesDechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.
Latest Interim Date21 Feb 2022
Latest Fiscal Year End Date6 Sep 2021

Dechra Pharmaceuticals PLC Directors

AppointedNamePosition
2021-09-14Mr. Julian HeslopNon-Executive Director
2013-10-17Mr. Neil W WarnerNon-Executive Director
2009-01-09Mr. Malcolm McDonald Diamond MBENon-Executive Director
2019-09-05Mr. Richard John CottonExecutive Director,Chief Financial Officer
2022-06-13Mr. Ian David PageExecutive Director,Chief Executive
2016-10-21Mr. Michael RedmondNon-Executive Director,Chairman
2021-12-29Mr. William Anthony RiceNon-Executive Director,Chairman
2021-09-14Ms. Ishbel Jean Stewart MacphersonNon-Executive Director,Senior Independent Non-Executive Director
2015-09-09Ms. Zoe GouldingCompany Secretary
2012-10-19Mr. Simon David EvansExecutive Director,Group Finance Director
2014-09-15Mr. Edwin Thomas William Torr Executive Director,MD, Dechra Veterinary Products Europe
2012-07-09Mr. Bryan Geoffrey MortonNon-Executive Director
2016-04-08Dr. Christopher Gareth Joseph RichardsNon-Executive Director
2022-04-05Ms. Alison Elizabeth Platt Non-Executive Director,Chairman
2021-10-06Mr. Paul SandlandExecutive Director,Chief Financial Officer
2021-09-22Mr. Anthony GriffinExecutive Director,Managing Director, Dechra Veterinary Products EU
2017-09-05Ms. Anne-Francoise NesmesExecutive Director,Chief Financial Officer
2021-09-14Dr. Lawson MacartneyNon-Executive Director
2021-09-14Ms. Lisa BrightNon-Executive Director
2022-02-21Ms. Denise GoodeNon-Executive Director

Dechra Pharmaceuticals PLC Contact Details

Company NameDechra Pharmaceuticals PLC
Address24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, CW9 7UA
Telephone+44 1606814730
Websitehttp://www.dechra.com

Dechra Pharmaceuticals PLC Advisors

AuditorPricewaterhouseCoopers LLP
Phone+44 1212655000
Fax+44 1212655050
BankRoyal Bank of Scotland PLC
RegistrarEquiniti Limited
Remuneration ConsultantDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
Financial PR AdviserTooleystreet Communications
SolicitorDLA Piper LLP
Phone+44 8700111111
Fax+44 1212625794
StockbrokerInvestec Securities
Phone+44 2075974000
Fax+44 2075974070
Financial AdviserInvestec Investment Banking
Phone +44 2075974000
Fax+44 20 75974070
BankHSBC Bank PLC
BankBarclays Bank PLC

Sign up to our
daily email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
23 Jun 2022Subscribe now

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Molten Ventures PLC467.005.23
Abrdn Private Equity Opportunities Trust PLC471.005.13
Tui AG153.204.97
Easyjet PLC413.004.58
Blackrock World Mining Trust PLC616.004.41
Ferrexpo PLC146.004.29

Fallers

CompanyPrice% Chg
Helios Towers PLC122.80-2.38
Abrdn PLC167.60-1.96
Jupiter Fund Management PLC158.00-1.56
Energean PLC1,136.00-1.47
Drax Group PLC645.00-1.45
Biffa PLC401.40-1.38